Labcorp Testing Facility & Clinic
Net lease laboratory/medical office (single-tenant) property in Tampa, FL — sponsored by Syndicated Equities
Files with the SEC as SE LCH (TAMPA), DST
Minimum investment
$10k
Offering size
$10.4M
How much has sold
97.0%
Asset type
Net lease laboratory/medical office (single-tenant) property
Location
Tampa, FL
Financing
Not stated. The filings for this offering do not say whether it carries mortgage debt.
Sponsor-reported, from SEC filings and cited sources.
What is this, in one paragraph?
A Delaware Statutory Trust — passive co-ownership whose interests qualify for 1031 exchange treatment — that owns one Tampa, Florida laboratory testing facility and clinic net leased to Labcorp. Syndicated Equities closed the acquisition on December 22, 2025.1 The Trust is still raising from accredited investors, those meeting SEC income or net-worth tests, under a private exemption that bars general advertising.
100% leased Labcorp (Labcorp Holdings gty, BBB); 9.5yr term, 2.75% esc; tenant 30 yrs; 50-60k samples/day
Show sources (6)Hide sources (6)
These links support the public record as a whole; individual details may come from different sources.
On a 45-day clock? Find day 45 and day 180 from the sale date, then come back to this record.
What exactly is the property?
Syndicated Equities closed on this single-story medical-testing and life-sciences building on December 22, 2025 and holds it in the Trust.1 The sponsor describes the site as mission-critical to Labcorp, processing roughly 50,000 to 60,000 blood and tissue samples a day.1 No public filing reviewed discloses the purchase price.
- Property address
- 5610 W La Salle St, Tampa, FL
- Property size
- ~94,686 SF
Who is the tenant, and what's the lease?
Laboratory Corporation of America occupies the entire building under a net lease — the tenant carries operating costs the lease assigns it.1 Syndicated Equities says Labcorp has been on the site for 30 years and extended for another 10 years, through May 2035.1 Offering materials cite a 9.5-year term, 2.75% annual escalations, and a BBB-rated Labcorp Holdings guaranty.
How are sales going?
These are the sponsor’s own numbers. They can lag what has actually sold, and they do not confirm that interests are still available.
97.0% reported sold
- Amount sold
- $10,081,045
- Still available
- $303,955
- Investors reported
- 38
- Total offering
- $10,385,000
Not enough filings yet to show a trend.
See how much of this offering has soldSign in by email and confirm you’re an accredited investor.
How is it financed, and what does it pay?
No reviewed public filing names a mortgage, a lender, or loan terms for this Trust, and no source states the building is owned free and clear. Whether property-level debt exists is settled only in the Private Placement Memorandum, the offering's disclosure document.
Who's behind it?
Syndicated Equities sponsors the Trust from Chicago; the February 13, 2026 Form D names SE LCH (TAMPA) DT, LLC as discretionary trustee and Syndicated Equities Interests, LLC as promoter and manager of that trustee entity.2 Its Winter 2026 investor newsletter, dated March 9, 2026, presented this Tampa purchase as a newly closed acquisition and said the deal was structured to take both cash and 1031 exchange investors.1
- Sponsor
- Syndicated Equities
- Legal Trust name
- SE LCH (TAMPA), DST
- May convert to a REIT
- No
- Offerings from this sponsor
- 4 active / 10 total offerings from Syndicated Equities
Reported by the sponsor. Top1031 does not independently audit sponsor-reported figures.
What does the paperwork say?
The Trust's only public paperwork is the initial notice of an exempt private offering; no amendment had appeared as of August 31, 2026. The exemption claimed bars general advertising, so the Private Placement Memorandum and subscription documents come from the sponsor rather than from any public source.
- Form D filedFirst and latest filing on record.
- Filings on record
- 1
- How it may be offered
- Rule 506(b)Not advertised publicly. Offered through existing relationships.
- Source filing
- Read the filings on SEC EDGAR
A Form D is the notice a sponsor files when it starts raising money. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.
DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current Private Placement Memorandum before investing.
Common questions
Is Labcorp Testing Facility & Clinic still raising money?
Top1031 lists Labcorp Testing Facility & Clinic as active because the sponsor is still filing with the SEC. That does not confirm that interests remain available.
Where does Top1031 get the data for Labcorp Testing Facility & Clinic?
Top1031 builds this record from the sponsor’s own SEC filings and cited sponsor disclosures. Filings can lag what is happening now. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.
What exactly does this Trust own?
One property: an approximately 94,686-square-foot single-tenant laboratory testing facility and patient clinic at 5610 W La Salle Street in Tampa, Florida, occupied by Labcorp. Investors hold beneficial interests in the Delaware Statutory Trust that owns the building, not direct title to the real estate.
Who is the tenant, and how long is the lease?
Laboratory Corporation of America occupies the entire building, with a guaranty from parent Labcorp Holdings that offering materials describe as BBB rated. Syndicated Equities reports Labcorp has occupied the site for 30 years and extended its lease an additional 10 years, running through May 2035. Offering materials also cite a 9.5-year term with 2.75% annual rent escalations.
Is the Trust leveraged?
The public record does not say. No lender, loan amount, or loan terms for this Trust were located in its SEC filing or in reviewed sponsor materials, and no source states the Trust is debt-free. The Private Placement Memorandum is the only place to confirm whether property-level debt exists and on what terms.
What is the stated minimum investment?
The Form D filed February 13, 2026 reports a $10,000 minimum accepted from any outside investor. Sponsors can and do apply higher practical minimums for 1031 exchange subscriptions, so the figure to rely on is the one in the Private Placement Memorandum and subscription documents.
How is the tenant's parent company performing?
Labcorp Holdings reported second-quarter 2026 revenue of $3.73 billion, up 5.8%, in its results release of July 30, 2026. The company trades on the NYSE under LH, so its financial disclosures are public. Tenant credit is not the same as property performance, and a company-wide release says nothing specific about the Tampa facility.
Is the offering still open?
The Trust is shown as raising. The sales module on this page reports the amount sold, the amount still available, and the investor count as stated in the Form D filed February 13, 2026 — the only filing on record. Form D figures can lag current subscriptions, so the sponsor is the only place to confirm what remains today.
Chapter 9Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 GuidanceLabcorp announced second-quarter 2026 results with revenue of $3.73 billion (up 5.8%) and raised its 2026 adjusted EPS guidance to $18.10–$18.55, providing major-tenant financial context for the Tampa facility. Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026BURLINGTON, N.C. announcement from Labcorp Holdings Inc. (NYSE: LH), the 100% net-lease tenant of the DST's Tampa testing facility and clinic, that it will release Q2 2026 financial results before market open on Thursday, July 30, 2026 and host a 9:00 a.m. ET webcast that day. Winter Access 2026 NewsletterSyndicated Equities' Winter 2026 sponsor newsletter references the Labcorp Testing Facility & Clinic in Tampa, FL as a recently closed acquisition (closed 12/22/25), noting the property processes 50,000-60,000 samples daily.